David Preiss

Summary

Country: UK

Publications

  1. ncbi request reprint Emerging therapeutic approaches to treat dyslipidemia
    David Preiss
    BHF Glasgow Cardiovascular Research Centre, University of Glasgow, Glasgow, G12 8TA, UK
    Curr Cardiol Rep 16:506. 2014
  2. doi request reprint Metformin for non-diabetic patients with coronary heart disease (the CAMERA study): a randomised controlled trial
    David Preiss
    BHF Glasgow Cardiovascular Research Centre, University of Glasgow, Glasgow, UK Electronic address
    Lancet Diabetes Endocrinol 2:116-24. 2014
  3. doi request reprint Predictors of stroke in patients with impaired glucose tolerance: results from the Nateglinide and Valsartan in Impaired Glucose Tolerance Outcomes Research trial
    David Preiss
    University of Glasgow, Glasgow, UK
    Stroke 44:2590-3. 2013
  4. doi request reprint Statins and the risk of new-onset diabetes: a review of recent evidence
    David Preiss
    BHF Glasgow Cardiovascular Research Centre, University of Glasgow, Glasgow, Scotland, UK
    Curr Opin Lipidol 22:460-6. 2011
  5. ncbi request reprint Lipid-modifying therapies and risk of pancreatitis: a meta-analysis
    David Preiss
    BHF Glasgow Cardiovascular Research Centre, University of Glasgow, 126 University Pl, Glasgow G12 8TA, United Kingdom
    JAMA 308:804-11. 2012
  6. doi request reprint A systematic review of event rates in clinical trials in diabetes mellitus: the importance of quantifying baseline cardiovascular disease history and proteinuria and implications for clinical trial design
    David Preiss
    BHF Cardiovascular Research Centre, University of Glasgow, Glasgow, United Kingdom
    Am Heart J 161:210-219.e1. 2011
  7. doi request reprint Risk of incident diabetes with intensive-dose compared with moderate-dose statin therapy: a meta-analysis
    David Preiss
    BHF Glasgow Cardiovascular Research Centre, University of Glasgow, 126 University Pl, Glasgow G12 8TA, Scotland, United Kingdom
    JAMA 305:2556-64. 2011
  8. doi request reprint The inverse relationship between alanine aminotransferase in the normal range and adverse cardiovascular and non-cardiovascular outcomes
    Ian Ford
    From the Robertson Centre for Biostatistics, University of Glasgow, Glasgow, Scotland
    Int J Epidemiol 40:1530-8. 2011
  9. doi request reprint Statins and risk of incident diabetes: a collaborative meta-analysis of randomised statin trials
    Naveed Sattar
    British Heart Foundation Glasgow Cardiovascular Research Centre, University of Glasgow, Glasgow, UK
    Lancet 375:735-42. 2010
  10. ncbi request reprint Fasting plasma glucose in non-diabetic participants and the risk for incident cardiovascular events, diabetes, and mortality: results from WOSCOPS 15-year follow-up
    David Preiss
    Faculty of Medicine, University of Glasgow, Glasgow, UK
    Eur Heart J 31:1230-6. 2010

Detail Information

Publications16

  1. ncbi request reprint Emerging therapeutic approaches to treat dyslipidemia
    David Preiss
    BHF Glasgow Cardiovascular Research Centre, University of Glasgow, Glasgow, G12 8TA, UK
    Curr Cardiol Rep 16:506. 2014
    ..Testing in major outcome trials will be required to demonstrate their clinical utility. ..
  2. doi request reprint Metformin for non-diabetic patients with coronary heart disease (the CAMERA study): a randomised controlled trial
    David Preiss
    BHF Glasgow Cardiovascular Research Centre, University of Glasgow, Glasgow, UK Electronic address
    Lancet Diabetes Endocrinol 2:116-24. 2014
    ..Metformin reduces cardiovascular risk in patients with type 2 diabetes seemingly independent of lowering blood glucose concentration. We assessed the cardiovascular effects of metformin in individuals without type 2 diabetes...
  3. doi request reprint Predictors of stroke in patients with impaired glucose tolerance: results from the Nateglinide and Valsartan in Impaired Glucose Tolerance Outcomes Research trial
    David Preiss
    University of Glasgow, Glasgow, UK
    Stroke 44:2590-3. 2013
    ..Risk factors for stroke are well-established in general populations but sparsely studied in individuals with impaired glucose tolerance...
  4. doi request reprint Statins and the risk of new-onset diabetes: a review of recent evidence
    David Preiss
    BHF Glasgow Cardiovascular Research Centre, University of Glasgow, Glasgow, Scotland, UK
    Curr Opin Lipidol 22:460-6. 2011
    ..We discuss the relevant data including newly published results, which demonstrate a dose-dependent association, we place these findings in clinical context and we consider clinical implications...
  5. ncbi request reprint Lipid-modifying therapies and risk of pancreatitis: a meta-analysis
    David Preiss
    BHF Glasgow Cardiovascular Research Centre, University of Glasgow, 126 University Pl, Glasgow G12 8TA, United Kingdom
    JAMA 308:804-11. 2012
    ..Although lipid guidelines recommend fibrate therapy to reduce pancreatitis risk in persons with hypertriglyceridemia, fibrates may lead to the development of gallstones, a risk factor for pancreatitis...
  6. doi request reprint A systematic review of event rates in clinical trials in diabetes mellitus: the importance of quantifying baseline cardiovascular disease history and proteinuria and implications for clinical trial design
    David Preiss
    BHF Cardiovascular Research Centre, University of Glasgow, Glasgow, United Kingdom
    Am Heart J 161:210-219.e1. 2011
    ....
  7. doi request reprint Risk of incident diabetes with intensive-dose compared with moderate-dose statin therapy: a meta-analysis
    David Preiss
    BHF Glasgow Cardiovascular Research Centre, University of Glasgow, 126 University Pl, Glasgow G12 8TA, Scotland, United Kingdom
    JAMA 305:2556-64. 2011
    ..A recent meta-analysis demonstrated that statin therapy is associated with excess risk of developing diabetes mellitus...
  8. doi request reprint The inverse relationship between alanine aminotransferase in the normal range and adverse cardiovascular and non-cardiovascular outcomes
    Ian Ford
    From the Robertson Centre for Biostatistics, University of Glasgow, Glasgow, Scotland
    Int J Epidemiol 40:1530-8. 2011
    ..High serum alanine aminotransferase (ALT) levels have been associated with increased risk of diabetes and with increased mortality, but associations of variations of ALT in the normal range with outcomes have been less well studied...
  9. doi request reprint Statins and risk of incident diabetes: a collaborative meta-analysis of randomised statin trials
    Naveed Sattar
    British Heart Foundation Glasgow Cardiovascular Research Centre, University of Glasgow, Glasgow, UK
    Lancet 375:735-42. 2010
    ..We aimed to establish by a meta-analysis of published and unpublished data whether any relation exists between statin use and development of diabetes...
  10. ncbi request reprint Fasting plasma glucose in non-diabetic participants and the risk for incident cardiovascular events, diabetes, and mortality: results from WOSCOPS 15-year follow-up
    David Preiss
    Faculty of Medicine, University of Glasgow, Glasgow, UK
    Eur Heart J 31:1230-6. 2010
    ..The evidence base for fasting plasma glucose (FPG) in the non-diabetic range as a risk factor for cardiovascular disease (CVD) is inconclusive. We investigated this question in the West of Scotland Coronary Prevention Study (WOSCOPS)...
  11. doi request reprint Eplerenone and new-onset diabetes in patients with mild heart failure: results from the Eplerenone in Mild Patients Hospitalization and Survival Study in Heart Failure (EMPHASIS-HF)
    David Preiss
    British Heart Foundation Cardiovascular Research Centre, University of Glasgow, Glasgow G12 8TA, UK
    Eur J Heart Fail 14:909-15. 2012
    ..In addition, though the combination of diabetes and chronic heart failure (CHF) carries a poor prognosis, few studies have examined predictors of new-onset diabetes in those with CHF...
  12. ncbi request reprint Liver enzymes, nonalcoholic fatty liver disease, and incident cardiovascular disease: a narrative review and clinical perspective of prospective data
    Nazim Ghouri
    BHF Glasgow Cardiovascular Research Centre, University of Glasgow, Glasgow, UK
    Hepatology 52:1156-61. 2010
    ..Finally, although some studies have linked imaging-defined and biopsy-confirmed NAFLD with CVD risk, the evidence is inconsistent, with few incident events and/or insufficient potential confounders...
  13. doi request reprint Lipids, lipid modifying agents and cardiovascular risk: a review of the evidence
    David Preiss
    BHF Glasgow Cardiovascular Research Centre, University of Glasgow, Glasgow, UK
    Clin Endocrinol (Oxf) 70:815-28. 2009
    ..Ongoing studies such as ACCORD, IMPROVE-IT, ASCEND, ORIGIN and HPS2-THRIVE should assist in answering outstanding questions over the next 5 years...
  14. pmc Predictors of development of diabetes in patients with chronic heart failure in the Candesartan in Heart Failure Assessment of Reduction in Mortality and Morbidity (CHARM) program
    David Preiss
    BHF Glasgow Cardiovascular Research Centre, University of Glasgow, Glasgow, Scotland, UK
    Diabetes Care 32:915-20. 2009
    ....
  15. ncbi request reprint Non-alcoholic fatty liver disease: an overview of prevalence, diagnosis, pathogenesis and treatment considerations
    David Preiss
    British Heart Foundation, Glasgow Cardiovascular Research Centre, University of Glasgow, 126 University Place, Glasgow G12 8TA, Scotland, UK
    Clin Sci (Lond) 115:141-50. 2008
    ..Furthermore, the cost/benefit ratio of any new therapies, and any potential harms, must be evaluated carefully before being clinically advocated...